Company intelligence / Profile preview

Peri-Swab

Ownership: Private
Development stage: Commercial

Overview

Peri offers a consumer-facing saliva swab test that analyzes the oral microbiome to assess risk for dental and systemic diseases. The results are used to generate personalized product and lifestyle recommendations. The service is marketed as proactive preventive care for overall health via at-home testing. No clinical trial data or peer-reviewed outcomes are reported on their website.

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceDiagnostic test
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Peri-Swab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peri-Swab.

Explore the full profile